Effect of 5-bromodeoxyuridine substitution on sister chromatid exchange induction by chemicals.
The fluorescence-plus-Giemsa (FPG) technique for analysis of sister chromatid exchange (SCE) is widely used as an assay for mutagenic carcinogens. There is very little information, however, on whether incorporation of the bromodeoxyuridine (BrdU) necessary for visualization of SCEs affects the sensitivity of the SCE test system to different chemical agents. We have investigated the effect of BrdU incorporation on SCE induction by labeling cells with BrdU for either the first cell cycle or the first and second cell cycles. The cells were then treated with bleomycin, which produces DNA strand breakage; proflavine, which intercalates into DNA; mitomycin C, which produces monoadducts and DNA crosslinks; or aphidicolin, which inhibits DNA polymerase alpha. Chemicals were added before BrdU exposure or during the first, second, or both cell cycles. Only mitomycin C, which induces long-lived lesions, elevated the SCE frequency when cells were treated before BrdU labeling. When bleomycin, proflavine, or mitomycin C was present concurrently with BrdU, the frequency of SCEs was increased independently of the BrdU labeling protocol. Aphidicolin, on the other hand, induced more SCEs when present for the second cell cycle, when DNA replicates on a template DNA strand containing BrdU. We also examined the induction of SCEs in the first cell cycle (twins) and in the second cell cycle (singles) after continuous treatment of cells with BrdU and the test chemicals. Only aphidicolin increased SCE frequency in the second cell cycle. These results indicate that aphidicolin, but not bleomycin, proflavine, or mitomycin C, affects BrdU-substituted DNA and unsubstituted DNA differently. This type of interaction should be taken into consideration when the SCE test is used as an assay system.
D000818:Animals; D016590:Aphidicolin; D001761:Bleomycin / Q000494:pharmacology; D001973:Bromodeoxyuridine / Q000378:metabolism*; D002453:Cell Cycle; D002478:Cells, Cultured; D006224:Cricetinae; D003412:Cricetulus; D003434:Crossing Over, Genetic / Q000187:drug effects*; D004247:DNA / Q000378:metabolism; D004224:Diterpenes / Q000494:pharmacology; D005260:Female; D016685:Mitomycin; D008937:Mitomycins / Q000494:pharmacology; D010053:Ovary; D011370:Proflavine / Q000494:pharmacology; D012854:Sister Chromatid Exchange / Q000187:drug effects*
D004224:Diterpenes; D008937:Mitomycins; D001761:Bleomycin; D016590:Aphidicolin; D016685:Mitomycin; D004247:DNA; D011370:Proflavine; D001973:Bromodeoxyuridine